Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aporphines | 14 | 2022 | 16 | 6.910 |
Why?
|
| Receptors, Dopamine D1 | 8 | 2023 | 40 | 4.950 |
Why?
|
| Structure-Activity Relationship | 23 | 2023 | 409 | 2.850 |
Why?
|
| Benzazepines | 4 | 2023 | 32 | 2.480 |
Why?
|
| Receptors, Serotonin | 4 | 2020 | 22 | 2.110 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 6 | 2016 | 16 | 2.040 |
Why?
|
| Receptors, Dopamine | 3 | 2023 | 25 | 2.010 |
Why?
|
| Ligands | 15 | 2023 | 349 | 1.960 |
Why?
|
| Berberine | 5 | 2020 | 6 | 1.650 |
Why?
|
| Diterpenes | 12 | 2012 | 92 | 1.620 |
Why?
|
| Molecular Structure | 16 | 2021 | 492 | 1.500 |
Why?
|
| Dopamine Antagonists | 6 | 2023 | 44 | 1.490 |
Why?
|
| Dopamine Agonists | 3 | 2020 | 30 | 1.480 |
Why?
|
| Receptors, Dopamine D3 | 5 | 2023 | 12 | 1.470 |
Why?
|
| Salvia | 6 | 2007 | 7 | 1.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 60 | 0.880 |
Why?
|
| Amides | 1 | 2023 | 68 | 0.870 |
Why?
|
| Diterpenes, Clerodane | 11 | 2008 | 11 | 0.850 |
Why?
|
| Plants, Medicinal | 5 | 2006 | 68 | 0.800 |
Why?
|
| Xylenes | 1 | 2021 | 2 | 0.790 |
Why?
|
| Furans | 4 | 2007 | 38 | 0.780 |
Why?
|
| Serotonin Antagonists | 2 | 2020 | 23 | 0.770 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2021 | 21 | 0.770 |
Why?
|
| Receptors, Dopamine D5 | 1 | 2020 | 2 | 0.730 |
Why?
|
| Azepines | 1 | 2020 | 17 | 0.720 |
Why?
|
| Alkaloids | 2 | 2018 | 39 | 0.690 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2021 | 1039 | 0.650 |
Why?
|
| Receptors, Opioid, kappa | 7 | 2008 | 22 | 0.580 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2016 | 6 | 0.560 |
Why?
|
| Amines | 1 | 2016 | 39 | 0.550 |
Why?
|
| Receptors, sigma | 1 | 2016 | 15 | 0.550 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2011 | 14 | 0.490 |
Why?
|
| Lamiaceae | 1 | 2012 | 3 | 0.430 |
Why?
|
| Receptors, Opioid, mu | 5 | 2008 | 55 | 0.430 |
Why?
|
| Receptors, GABA-A | 1 | 2012 | 64 | 0.410 |
Why?
|
| Humans | 24 | 2023 | 37093 | 0.410 |
Why?
|
| Cocaine | 3 | 2020 | 232 | 0.400 |
Why?
|
| Stereoisomerism | 6 | 2012 | 167 | 0.380 |
Why?
|
| Binding Sites | 5 | 2023 | 651 | 0.380 |
Why?
|
| Acetylcholinesterase | 1 | 2010 | 55 | 0.360 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2010 | 43 | 0.360 |
Why?
|
| Receptors, Opioid, delta | 3 | 2007 | 23 | 0.360 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2009 | 8 | 0.360 |
Why?
|
| Molecular Conformation | 4 | 2020 | 152 | 0.340 |
Why?
|
| Extinction, Psychological | 2 | 2020 | 90 | 0.310 |
Why?
|
| Caco-2 Cells | 2 | 2022 | 52 | 0.310 |
Why?
|
| Cocaine-Related Disorders | 2 | 2016 | 85 | 0.270 |
Why?
|
| Animals | 16 | 2020 | 15081 | 0.270 |
Why?
|
| Pyrones | 1 | 2005 | 9 | 0.270 |
Why?
|
| Narcotic Antagonists | 1 | 2005 | 57 | 0.260 |
Why?
|
| Algorithms | 2 | 2023 | 465 | 0.250 |
Why?
|
| Analgesics, Opioid | 2 | 2006 | 197 | 0.250 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 174 | 0.230 |
Why?
|
| Protein Binding | 3 | 2023 | 972 | 0.220 |
Why?
|
| Catechols | 1 | 2022 | 5 | 0.210 |
Why?
|
| Pregnanes | 1 | 2001 | 1 | 0.190 |
Why?
|
| Meliaceae | 1 | 2001 | 1 | 0.190 |
Why?
|
| Saponins | 1 | 2001 | 6 | 0.190 |
Why?
|
| Ergosterol | 1 | 2001 | 12 | 0.190 |
Why?
|
| Triterpenes | 1 | 2001 | 14 | 0.190 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2020 | 9 | 0.180 |
Why?
|
| Halogenation | 1 | 2020 | 19 | 0.180 |
Why?
|
| Proteins | 1 | 2023 | 369 | 0.180 |
Why?
|
| Hydrogen Bonding | 1 | 2020 | 132 | 0.180 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2020 | 77 | 0.170 |
Why?
|
| Reward | 2 | 2018 | 79 | 0.170 |
Why?
|
| Cell Line | 3 | 2020 | 1354 | 0.170 |
Why?
|
| Schistosoma mansoni | 1 | 2018 | 18 | 0.160 |
Why?
|
| Amino Acids | 1 | 2019 | 145 | 0.160 |
Why?
|
| Models, Chemical | 2 | 2010 | 207 | 0.160 |
Why?
|
| Self Administration | 1 | 2018 | 42 | 0.160 |
Why?
|
| Cues | 1 | 2018 | 55 | 0.160 |
Why?
|
| Kinetics | 2 | 2010 | 708 | 0.160 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 730 | 0.160 |
Why?
|
| Serotonin | 1 | 2018 | 123 | 0.150 |
Why?
|
| CHO Cells | 3 | 2007 | 124 | 0.150 |
Why?
|
| Cricetinae | 3 | 2007 | 238 | 0.150 |
Why?
|
| Biological Products | 1 | 2018 | 71 | 0.150 |
Why?
|
| Water | 1 | 2019 | 296 | 0.150 |
Why?
|
| Models, Molecular | 2 | 2010 | 808 | 0.140 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 5 | 0.140 |
Why?
|
| Receptors, Opioid | 2 | 2006 | 51 | 0.140 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2016 | 73 | 0.140 |
Why?
|
| Rats | 5 | 2020 | 3483 | 0.130 |
Why?
|
| Thermodynamics | 2 | 2019 | 216 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2019 | 133 | 0.120 |
Why?
|
| Plant Leaves | 3 | 2005 | 124 | 0.120 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2005 | 84 | 0.110 |
Why?
|
| Radioligand Assay | 3 | 2008 | 66 | 0.100 |
Why?
|
| HCT116 Cells | 1 | 2011 | 35 | 0.100 |
Why?
|
| Crystallography, X-Ray | 3 | 2007 | 265 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2011 | 113 | 0.100 |
Why?
|
| Hallucinogens | 3 | 2005 | 28 | 0.090 |
Why?
|
| Electrophorus | 1 | 2010 | 3 | 0.090 |
Why?
|
| Rhodopsin | 1 | 2010 | 36 | 0.090 |
Why?
|
| Spectrophotometry | 1 | 2010 | 70 | 0.090 |
Why?
|
| Iodobenzenes | 1 | 2009 | 2 | 0.090 |
Why?
|
| Fluoroacetates | 1 | 2009 | 2 | 0.090 |
Why?
|
| Ketanserin | 1 | 2009 | 4 | 0.090 |
Why?
|
| Trifluoroacetic Acid | 1 | 2009 | 2 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2010 | 109 | 0.090 |
Why?
|
| Appetite Depressants | 1 | 2009 | 9 | 0.090 |
Why?
|
| Cyclization | 1 | 2009 | 48 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 408 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 186 | 0.080 |
Why?
|
| Cricetulus | 2 | 2007 | 80 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2009 | 83 | 0.080 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 71 | 0.080 |
Why?
|
| Cattle | 1 | 2010 | 477 | 0.080 |
Why?
|
| Arrestins | 1 | 2008 | 27 | 0.080 |
Why?
|
| Carbon | 1 | 2009 | 105 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 362 | 0.080 |
Why?
|
| Drug Design | 1 | 2009 | 162 | 0.080 |
Why?
|
| Mass Spectrometry | 3 | 2008 | 260 | 0.070 |
Why?
|
| Arrestin | 1 | 2006 | 7 | 0.070 |
Why?
|
| Mice | 3 | 2018 | 5913 | 0.070 |
Why?
|
| Sapogenins | 1 | 2005 | 3 | 0.070 |
Why?
|
| Endocytosis | 1 | 2006 | 113 | 0.070 |
Why?
|
| Calcium | 1 | 2009 | 480 | 0.070 |
Why?
|
| Dioscorea | 1 | 2005 | 3 | 0.070 |
Why?
|
| Steroids | 1 | 2005 | 43 | 0.070 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 160 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 421 | 0.050 |
Why?
|
| DNA | 1 | 2006 | 574 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 905 | 0.050 |
Why?
|
| Euphorbiaceae | 1 | 2001 | 2 | 0.050 |
Why?
|
| Chromatography | 1 | 2001 | 16 | 0.050 |
Why?
|
| Plant Stems | 1 | 2001 | 10 | 0.050 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2001 | 37 | 0.050 |
Why?
|
| Chemistry, Physical | 1 | 2001 | 45 | 0.050 |
Why?
|
| Chemical Phenomena | 1 | 2001 | 54 | 0.050 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2001 | 98 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 89 | 0.050 |
Why?
|
| Conditioning, Classical | 1 | 2020 | 61 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 42 | 0.040 |
Why?
|
| Schistosomiasis | 1 | 2018 | 12 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2020 | 314 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 86 | 0.040 |
Why?
|
| Locomotion | 1 | 2018 | 97 | 0.040 |
Why?
|
| Male | 4 | 2020 | 20025 | 0.040 |
Why?
|
| Fluorenes | 1 | 2016 | 26 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 227 | 0.030 |
Why?
|
| Piperazines | 1 | 2016 | 111 | 0.030 |
Why?
|
| Macaca mulatta | 2 | 2005 | 128 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2008 | 289 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1618 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1371 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2006 | 40 | 0.020 |
Why?
|
| Morphine | 1 | 2006 | 85 | 0.020 |
Why?
|
| Amylases | 1 | 2005 | 3 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2005 | 25 | 0.020 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 16 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 62 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2005 | 26 | 0.020 |
Why?
|
| Narcotics | 1 | 2005 | 32 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2005 | 28 | 0.020 |
Why?
|
| Protein Transport | 1 | 2006 | 302 | 0.020 |
Why?
|
| Intestines | 1 | 2005 | 64 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 523 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 82 | 0.020 |
Why?
|
| Deuterium | 1 | 2004 | 12 | 0.020 |
Why?
|
| Body Fluids | 1 | 2004 | 17 | 0.020 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 30 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 94 | 0.020 |
Why?
|
| Eating | 1 | 2005 | 166 | 0.010 |
Why?
|
| Female | 2 | 2018 | 20969 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2005 | 230 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 2004 | 142 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2005 | 353 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 562 | 0.010 |
Why?
|
| Body Weight | 1 | 2005 | 434 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 935 | 0.010 |
Why?
|
| Jamaica | 1 | 2001 | 11 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2004 | 286 | 0.010 |
Why?
|
| Methylation | 1 | 2001 | 113 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 1742 | 0.010 |
Why?
|
| Brain | 1 | 2005 | 1346 | 0.010 |
Why?
|